Search Within

Maura N Dickler

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (61)
  2. Journal Article (43)
  3. Book Section (1)
Groups
  1. Epidemiology and Biostatistics (105)
  2. Survivorship Research (97)
  3. Department of Medicine (96)
  4. Solid Tumor Oncology Division (96)
  5. Breast Medicine Service (95)
  6. Population Sciences Research Program (83)

More Groups

People
  1. Clifford Hudis (64)
  2. Shari Goldfarb (51)
  3. Larry Norton (40)
  4. Sujata Patil (35)
  5. Chau Dang (28)
  6. Diana Lake (24)

More People

Years
  1. 2021 (1)
  2. 2020 (5)
  3. 2019 (2)
  4. 2018 (8)
  5. 2017 (10)
  6. 2016 (5)

More Years

Publications
  1. Journal of Clinical Oncology (27)
  2. Cancer Research (21)
  3. Breast Cancer Research and Treatment (7)
  4. Clinical Cancer Research (7)
  5. Journal of Sexual Medicine (7)
  6. Fertility and Sterility (5)

More Publications

Publishers
  1. American Association for Cancer Research (30)
  2. American Society of Clinical Oncology (28)
  3. Elsevier Inc. (11)
  4. Springer (9)
  5. Elsevier Science, Inc. (5)
  6. Oxford University Press (5)

More Publishers

Results (105)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bevacizumab for advanced breast cancer
    Journal Article

    Goldfarb, S. B.; Traina, T. A.; Dickler, M. N.
    Women's Health (2010)

    Fulltext@MSK | Save
  • Sexual dysfunction in women with breast cancer: Prevalence and severity
    Meeting Abstract

    Goldfarb, S. B.; Dickler, M.; Sit, L.; Fruscione, M.; Barz, T.; Atkinson, T.; Hudis, C.; Basch, E.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Evaluation of the correlation of baseline blood pressure (BP) and plasma renin activity (PRA) with bevacizumab (B)-mediated hypertension in patients with early-stage breast cancer
    Meeting Abstract

    Dickler, M. N.; McArthur, H. L.; Nulsen, B.; Patil, S.; Sealey, J.; Laragh, J.; Merali, C.; Steingart, R.; Hudis, C.; Rugo, H.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Androgen receptor inhibition can stabilize disease in patients with AR(+), ER(-)/PR(-) metastatic breast cancer
    Meeting Abstract

    Traina, T. A.; Feigin, K.; Patil, S.; Yuan, J.; Dickler, M.; Andrea, G. D.; Bromberg, J.; Hudis, C.
    Annals of Oncology (2009)

    Fulltext@MSK | Save
  • Cardiac safety of adjuvant bevacizumab (B) plus dose-dense doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel (nab-P) in patients with early stage breast cancer
    Meeting Abstract

    Mcarthur, H.; Rugo, H.; Nulsen, B.; Traina, T.; Patil, S.; Zhou, Q.; Steingart, R.; Dang, C.; Park, J.; Moasser, M.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Bone scintigraphy (BS) may no longer be relevant in the era of integrated PET/CT for women undergoing evaluation for suspected metastatic breast cancer (MBC)
    Meeting Abstract

    Mcarthur, H. L.; Lynch, C.; Morris, P.; Larson, S.; Grabski, K.; Howard, J.; Patil, S.; Hudis, C. A.; Dickler, M. N.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Long-term health outcomes of a decision aid: Data from a randomized trial of Adjuvant! in women with localized breast cancer
    Journal Article

    Vickers, A. J.; Elkin, E. B.; Peele, P. B.; Dickler, M.; Siminoff, L. A.
    Medical Decision Making (2009)

    Fulltext@MSK | Save
  • Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer
    Journal Article

    Traina, T. A.; Poggesi, I.; Robson, M.; Asnis, A.; Duncan, B. A.; Heerdt, A.; Dang, C.; Lake, D.; Moasser, M.; Panageas, K.; more...
    Breast Cancer Research and Treatment (2008)

    Fulltext@MSK | Save
  • A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer
    Journal Article

    Dickler, M. N.; Rugo, H. S.; Eberle, C.; Brogi, E.; Caravelli, J.; Panageas, K. S.; Boyd, J.; Yeh, B.; Lake, D. E.; Dang, C.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer
    Journal Article

    Dang, C.; Fornier, M.; Sugarman, S.; Troso-Sandoval, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Dickler, M.; Currie, V.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save